Among the most recent advances in gastroenterology, colonoscopy with artificial intelligence is associated with higher screening quality. Ozanimod seems to be an exciting salvage treatment in refractory UC, which still needs to be validated by Swiss medic. Rivaroxaban is the direct-acting anticoagulant most commonly associated with GI bleeding. The Chicago v4.0 classification of oesophageal motor disorders should be used in diagnostic management, as it was recently revised. Semaglutide appears to have promising results in the treatment of metabolic steatosis. Biliary tract disease can progress to hepatocellular failure and complicate SARS-CoV-2 infection. Track 13: Digestive Disorders